Major glycosaminoglycan species in the developing retina: synthesis, tissue distribution and effects upon cell death.
Retinal explants maintained in culture medium retain their histotypic structure and develop similarly to the in vivo condition. Extracellular matrix components, particularly the glycosaminoglycans which are not routinely present in dissociated cell cultures are involved in various cellular events. In this work we characterized and determined the localization of sulfated glycosaminoglycans in the extracellular matrix of rat retinal explants at various stages of normal postnatal development and tested whether disruption of the tissue glycosaminoglycan composition may impose either trophic or toxic effects upon distinct retinal cell populations. Our data show that chondroitin sulfate and heparan sulfate glycosaminoglycan chains are synthesized in different proportions during postnatal retinal development. A peak of synthesis of chondroitin sulfates is evident at around P14. Immunohistochemistry showed chondroitin 6-sulfate in the plexiform layers during the earlier stages while later, intense immunoreactivity was found in the outer retina. Heparan sulfate was found in the neuroblastic layer (NBL) at P1, in both nuclear layers from P5 onwards and in the ganglion cell layer (GCL) at all stages. In contrast to chondroitin 6-sulfate, immunoreactivity to heparan sulfate was absent from the outer retina at both P14 and P21. Treatment with heparitinase modulated the rates of cell death in both the GCL and the NBL in P1 retinal explants. Taken together our data show that among the major sulfated glycosaminoglycans, the developing rat retina synthesizes only heparan sulfate and chondroitin sulfates in a spatiotemporally regulated manner, with a peak of chondroitin sulfates at P14, possibly related to photoreceptor differentiation. In addition, our data suggest a role for heparan sulfate as a modulator of sensitivity to cell death in the retina.
Erlich
Rafael B
RB
Instituto de Biofísica da UFRJ, Rio de Janeiro, RJ, Brazil. erlich@anato.ufrj.br
Werneck
Cláudio C
CC
Mourão
Paulo A S
PA
Linden
Rafael
R
D000818:Animals; D016923:Cell Death / Q000187:drug effects; D019765:Chondroitin ABC Lyase / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000378:metabolism*; D007150:Immunohistochemistry; D011133:Polysaccharide-Lyases / Q000494:pharmacology; D051381:Rats; D012160:Retina / Q000254:growth & development* / Q000378:metabolism; D014018:Tissue Distribution
D006025:Glycosaminoglycans; D011133:Polysaccharide-Lyases; D019765:Chondroitin ABC Lyase; C021349:heparitinsulfate lyase